Arcus Biosciences (RCUS) EBIT Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3,724.00 |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - | -35,252.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,252.00 |
| Dec 31, 2025 | 5,070.00 |
| Sep 30, 2025 | -32,740.00 |
| Jun 30, 2025 | 26,679.00 |
| Mar 31, 2025 | -42,468.00 |
| Dec 31, 2024 | 25,385.00 |
| Sep 30, 2024 | 3,125.00 |
| Jun 30, 2024 | 1,441.00 |
| Mar 31, 2024 | 33,297.00 |
| Dec 31, 2023 | -43,235.00 |
| Sep 30, 2023 | -3,788.00 |
| Jun 30, 2023 | -3,065.00 |
| Mar 31, 2023 | 2,822.00 |
| Dec 31, 2022 | -29,689.00 |
| Sep 30, 2022 | 61,375.00 |
| Jun 30, 2022 | 54,918.00 |
| Mar 31, 2022 | 39,669.00 |
| Dec 31, 2021 | 62,501.00 |
| Sep 30, 2021 | -82,828.00 |
| Jun 30, 2021 | 178,812.00 |
| Mar 31, 2021 | 85,394.00 |
| Dec 31, 2020 | -36,600.00 |
| Sep 30, 2020 | 133,092.00 |
| Jun 30, 2020 | -92,657.00 |
| Mar 31, 2020 | -55,011.00 |
| Dec 31, 2019 | 68,349.00 |
| Sep 30, 2019 | -104,548.00 |
| Jun 30, 2019 | -39,437.00 |
| Mar 31, 2019 | -626.00 |
| Dec 31, 2018 | 20,427.00 |
| Sep 30, 2018 | 1.39 Mn |